Literature DB >> 2408655

Non-benign sickle cell anaemia in western Saudi Arabia.

J K Acquaye, A Omer, K Ganeshaguru, S A Sejeny, A V Hoffbrand.   

Abstract

Seventy-one Saudi and Yemeni Arabs with sickle cell anaemia from western Saudi Arabia aged between 1 1/2 and 42 years were studied. The mean steady state haemoglobin concentration of 8.1 g/dl was lower than that of 10.7 g/dl reported previously for sickle cell anaemia in eastern Saudi Arabia. The patients were divided into an SSLF group with fetal haemoglobin (HbF) of 10.0% or below (44 patients) and an SSHF group having HbF above 10.0% (27 patients). No significant differences were found in the haemoglobin concentrations, haematological indices and incidences of bone changes of the two groups. SSLF patients were significantly more prone to infections (P less than 0.01), however. Also, there was an overall high incidence of hepatomegaly (69.0%) and splenomegaly (54.9%) and hepatomegaly was significantly more common in the SSLF group (P less than 0.02). Many of the patients, even with HbF levels over 10.0%, did not follow a benign course and suffered from severe anaemia, infections of the respiratory and urinary tracts, bone pains and infarcts, or bossing of the skull. Rarer complications included hepatic crisis, chest syndrome, retinal haemorrhage, epistaxis and hemiplegia. It is therefore apparent that Saudi Arabian sickle cell anaemia, even in patients with raised haemoglobin F levels, may be as clinically severe as in African patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408655     DOI: 10.1111/j.1365-2141.1985.tb07390.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Orthopaedic complications in sickle cell disease. A comparative study from two regions in Saudi Arabia.

Authors:  M Sadat-Ali; S S Geeranavar; S As-Suhaimi
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

Review 2.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

3.  Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation.

Authors:  A E Kulozik; J S Wainscoat; G R Serjeant; B C Kar; B Al-Awamy; G J Essan; A G Falusi; S K Haque; A M Hilali; S Kate
Journal:  Am J Hum Genet       Date:  1986-08       Impact factor: 11.025

4.  Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease.

Authors:  N Nduka; Y Kazem; B Saleh
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

5.  Amelioration of clinical severity through raised fetal hemoglobin in sickle cell anaemia.

Authors:  S Ponnazhagan; R Sarkar
Journal:  Indian J Pediatr       Date:  1992 Jan-Feb       Impact factor: 1.967

6.  Analysis of hemoglobin electrophoresis results and physicians investigative practices in Saudi Arabia.

Authors:  Syed Riaz Mehdi; Badr Abdullah Al Dahmash
Journal:  Indian J Hum Genet       Date:  2013-07

7.  Acute Crises and Complications of Sickle Cell Anemia Among Patients Attending a Pediatric Tertiary Unit in Kinshasa, Democratic Republic Of Congo.

Authors:  Michel Ntetani Aloni; Bertin Tshimanga Kadima; Pépé Mfutu Ekulu; Aléine Nzazi Budiongo; René Makuala Ngiyulu; Jean Lambert Gini-Ehungu
Journal:  Hematol Rep       Date:  2017-06-01

8.  Sickle Cell Disease Clinical Trials and Phenotypes.

Authors:  Chinedu A Ezekekwu; Taiwo R Kotila; Titilola S Akingbola; Guillaume Lettre; Victor R Gordeuk; Richard S Cooper; Michael R DeBaun; Baba Inusa; Bamidele O Tayo
Journal:  J Trop Dis Public Health       Date:  2018-04-08

Review 9.  Hemoglobinopathies in Iran: An Updated Review.

Authors:  Abolfazl Nasiri; Zohreh Rahimi; Asad Vaisi-Raygani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.